NOVAVAX to Report First Quarter 2012 Financial Results on May 4, 2012
26 avr. 2012 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., April 26, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report its 2012 first-quarter financial results on Friday, May 4, 2012, before the U.S....
NOVAVAX to Present at the 11th Annual Needham Healthcare Conference
03 avr. 2012 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., April 3, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Frederick W. Driscoll, Vice President and Chief Financial Officer...
NOVAVAX to Present Results From Phase I RSV Study at XIV International Symposium on Respiratory Viral Infections
22 mars 2012 09h52 HE
|
Novavax, Inc.
ROCKVILLE, Md., March 22, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that Louis F. Fries III, M.D., its Vice President, Clinical and Medical Affairs, will present results...
NOVAVAX to Present at the 24th Annual ROTH Conference
12 mars 2012 10h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., March 12, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of...
NOVAVAX Reports Fourth Quarter and 2011 Year-End Financial Results
09 mars 2012 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., March 9, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced financial results for the fourth quarter and year ended December 31, 2011.
For the fourth quarter of...
NOVAVAX Appoints John A. Herrmann III, Vice President and General Counsel
08 mars 2012 09h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., March 8, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the appointment of Mr. John A. Herrmann III to the position of Vice President and General Counsel. Mr....
NOVAVAX Launches Phase II Clinical Trial of Seasonal Influenza Vaccine
01 mars 2012 16h30 HE
|
Novavax, Inc.
ROCKVILLE, Md., March 1, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it has begun enrollment in a Phase II clinical trial of its quadrivalent seasonal influenza...
NOVAVAX to Report 2011 Fourth-Quarter and Year-End Financial Results on March 9, 2012
24 févr. 2012 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., Feb. 24, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report its 2011 fourth-quarter and year-end financial results on Friday, March 9, 2012,...
NOVAVAX to Present at the 14th Annual Bio CEO & Investor Conference
10 févr. 2012 10h45 HE
|
Novavax, Inc.
ROCKVILLE, Md., Feb. 10, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Frederick W. Driscoll, Vice President and Chief Financial Officer...
NOVAVAX Appoints Mervyn L. Hamer, Vice President of Manufacturing
01 févr. 2012 14h53 HE
|
Novavax, Inc.
ROCKVILLE, Md., Feb. 1, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the appointment of Mr. Mervyn L. Hamer to the position of Vice President of Manufacturing. In this role,...